Three health workers in Norway who had recently received the AstraZeneca Covid-19 vaccine are being treated in hospital for bleeding, blood clots, and a low count of blood platelets, Norwegian health authorities said on Saturday.
Norway halted the rollout of the AstraZeneca vaccine on Thursday, following a similar move by Denmark. Iceland later followed suit.
“We do not know if the cases are linked to the vaccine,” Sigurd Hortemo, a senior doctor at the Norwegian Medicines Agency told a news conference held jointly with the Norwegian Institute of Public Health.
All three individuals were under the age of 50.
The European medicine regulator, the European Medicines Agency (EMA,) would investigate the three incidents, Hortemo said.
“They have very unusual symptoms: bleeding, blood clots and a low count of blood platelets,” Steinar Madsen, Medical Director at the Norwegian Medicines Agency told broadcaster NRK.
“They are quite sick...We take this very seriously,” he said, adding that authorities had received notification of the cases on Saturday.
AstraZeneca said an analysis of its safety data covering reported cases from over 17 million vaccine doses given had shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia - having low levels of platelets.
“In fact, the reported numbers of these types of events for COVID-19 Vaccine AstraZeneca are not greater than the number that would have occurred naturally in the unvaccinated population,” a company spokeswoman said.
Such trends or patterns were also not observed during clinical trials for the vaccine, she added.
Before Denmark and Norway stopped their rollout of the AstraZeneca vaccine, Austria stopped using a batch of the shots while investigating a death from coagulation disorders and an illness from a pulmonary embolism.
The EMA said on Thursday the vaccine’s benefits outweighed its risks and that it could continue to be administered.
Europe is struggling to speed up a vaccine rollout after delivery delays from Pfizer and AstraZeneca, even though new cases have spiked in some countries.
Latest Stories
-
Appiatse reconstruction: Support Bawumia to do more for Ghana – Richard Ahiagbah to Ghanaians
55 seconds -
I wanted Harry Kane at Man United – Ten Hag
3 mins -
Ayorkumi: Stage play on slave trade premieres on May 11
3 mins -
Majority defends GRA-SML deal, insists no wrong was done
11 mins -
Church Of Pentecost disburses educational sponsorships worth ¢14,281,540 million
11 mins -
Money Summit: Fidelity Bank’s Atta Gyan calls for a rethink on investment strategies
27 mins -
WPL 2023/24: Battle for glory as Northern and Southern zone clubs chase playoff spots
35 mins -
Ghana’s Press Freedom Index improvement nothing to write home about – Sam George
42 mins -
Ghana Wellness and Healthcare Awards slated for June 14
45 mins -
OSP begins investigation into alleged bribery of EC staff by Kwadaso MP
50 mins -
Ghana FA laud Coach Zito with standing ovation after Dreams FC’s exploit in Africa
52 mins -
Asantehene worried over brain drain in African contemporary arts
56 mins -
Hearts of Oak legend berates current players for poor form
1 hour -
Unless EC has rules against officials receiving lunch money, nothing can be done in ‘envelope scandal’ – Prof Agyeman Duah
1 hour -
Singer Ayra Starr releases artwork, track list for ‘Sophomore Album’
1 hour